The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK

Solmi Cheon, Kiran Kaur, Nadine Nijem, Islam Oguz Tuncay, Pooja Kumar, Milan Dean, Jane Juusola, Maria J. Guillen-Sacoto, Emma Bedoukian, Lynne Ierardi-Curto, Paige Kaplan, G. Bradley Schaefer, Prashant Mishra, Maria Chahrour

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Kaufman oculocerebrofacial syndrome (KOS) is a recessive neurodevelopmental disorder characterized by intellectual disability and lack of speech. KOS is caused by inactivating mutations in UBE3B, but the underlying biological mechanisms are completely unknown. We found that loss of Ube3b in mice resulted in growth retardation, decreased grip strength, and loss of vocalization. The brains of Ube3b / mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex. Ube3b / cortical neurons had abnormal dendritic morphology and synapses. We identified 22 UBE3B interactors and found that branched-chain α-ketoacid dehydrogenase kinase (BCKDK) is an in vivo UBE3B substrate. Since BCKDK targets several metabolic pathways, we profiled plasma and cortical metabolomes from Ube3b /− mice. Nucleotide metabolism and the tricarboxylic acid cycle were among the pathways perturbed. Substrate-induced mitochondrial respiration was reduced in skeletal muscle but not in liver of Ube3b / mice. To assess the relevance of these findings to humans, we identified three KOS patients who had compound heterozygous UBE3B mutations. We discovered changes in metabolites from similar pathways in plasma from these patients. Collectively, our results implicate a disease mechanism in KOS, suggest that it is a metabolic encephalomyopathy, and provide an entry to targeted therapies.

Original languageEnglish (US)
Pages (from-to)3662-3667
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume116
Issue number9
DOIs
StatePublished - Feb 26 2019

Fingerprint

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
Ligases
Ubiquitin
Metabolic Networks and Pathways
Intellectual Disability
Phosphotransferases
Mutation
Somatosensory Cortex
Citric Acid Cycle
Metabolome
Corpus Callosum
Hand Strength
Synapses
Respiration
Skeletal Muscle
Nucleotides
Neurons
Kaufman oculocerebrofacial syndrome
Liver
Brain

Keywords

  • Autism spectrum disorder
  • BCKDK
  • Intellectual disability
  • UBE3B
  • Ubiquitination

ASJC Scopus subject areas

  • General

Cite this

The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK. / Cheon, Solmi; Kaur, Kiran; Nijem, Nadine; Tuncay, Islam Oguz; Kumar, Pooja; Dean, Milan; Juusola, Jane; Guillen-Sacoto, Maria J.; Bedoukian, Emma; Ierardi-Curto, Lynne; Kaplan, Paige; Bradley Schaefer, G.; Mishra, Prashant; Chahrour, Maria.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, No. 9, 26.02.2019, p. 3662-3667.

Research output: Contribution to journalArticle

Cheon, S, Kaur, K, Nijem, N, Tuncay, IO, Kumar, P, Dean, M, Juusola, J, Guillen-Sacoto, MJ, Bedoukian, E, Ierardi-Curto, L, Kaplan, P, Bradley Schaefer, G, Mishra, P & Chahrour, M 2019, 'The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK', Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 9, pp. 3662-3667. https://doi.org/10.1073/pnas.1818751116
Cheon, Solmi ; Kaur, Kiran ; Nijem, Nadine ; Tuncay, Islam Oguz ; Kumar, Pooja ; Dean, Milan ; Juusola, Jane ; Guillen-Sacoto, Maria J. ; Bedoukian, Emma ; Ierardi-Curto, Lynne ; Kaplan, Paige ; Bradley Schaefer, G. ; Mishra, Prashant ; Chahrour, Maria. / The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK. In: Proceedings of the National Academy of Sciences of the United States of America. 2019 ; Vol. 116, No. 9. pp. 3662-3667.
@article{76485a84a0d14d09a5158d6816e03767,
title = "The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK",
abstract = "Kaufman oculocerebrofacial syndrome (KOS) is a recessive neurodevelopmental disorder characterized by intellectual disability and lack of speech. KOS is caused by inactivating mutations in UBE3B, but the underlying biological mechanisms are completely unknown. We found that loss of Ube3b in mice resulted in growth retardation, decreased grip strength, and loss of vocalization. The brains of Ube3b − / − mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex. Ube3b − / − cortical neurons had abnormal dendritic morphology and synapses. We identified 22 UBE3B interactors and found that branched-chain α-ketoacid dehydrogenase kinase (BCKDK) is an in vivo UBE3B substrate. Since BCKDK targets several metabolic pathways, we profiled plasma and cortical metabolomes from Ube3b − /− mice. Nucleotide metabolism and the tricarboxylic acid cycle were among the pathways perturbed. Substrate-induced mitochondrial respiration was reduced in skeletal muscle but not in liver of Ube3b − / − mice. To assess the relevance of these findings to humans, we identified three KOS patients who had compound heterozygous UBE3B mutations. We discovered changes in metabolites from similar pathways in plasma from these patients. Collectively, our results implicate a disease mechanism in KOS, suggest that it is a metabolic encephalomyopathy, and provide an entry to targeted therapies.",
keywords = "Autism spectrum disorder, BCKDK, Intellectual disability, UBE3B, Ubiquitination",
author = "Solmi Cheon and Kiran Kaur and Nadine Nijem and Tuncay, {Islam Oguz} and Pooja Kumar and Milan Dean and Jane Juusola and Guillen-Sacoto, {Maria J.} and Emma Bedoukian and Lynne Ierardi-Curto and Paige Kaplan and {Bradley Schaefer}, G. and Prashant Mishra and Maria Chahrour",
year = "2019",
month = "2",
day = "26",
doi = "10.1073/pnas.1818751116",
language = "English (US)",
volume = "116",
pages = "3662--3667",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "9",

}

TY - JOUR

T1 - The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK

AU - Cheon, Solmi

AU - Kaur, Kiran

AU - Nijem, Nadine

AU - Tuncay, Islam Oguz

AU - Kumar, Pooja

AU - Dean, Milan

AU - Juusola, Jane

AU - Guillen-Sacoto, Maria J.

AU - Bedoukian, Emma

AU - Ierardi-Curto, Lynne

AU - Kaplan, Paige

AU - Bradley Schaefer, G.

AU - Mishra, Prashant

AU - Chahrour, Maria

PY - 2019/2/26

Y1 - 2019/2/26

N2 - Kaufman oculocerebrofacial syndrome (KOS) is a recessive neurodevelopmental disorder characterized by intellectual disability and lack of speech. KOS is caused by inactivating mutations in UBE3B, but the underlying biological mechanisms are completely unknown. We found that loss of Ube3b in mice resulted in growth retardation, decreased grip strength, and loss of vocalization. The brains of Ube3b − / − mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex. Ube3b − / − cortical neurons had abnormal dendritic morphology and synapses. We identified 22 UBE3B interactors and found that branched-chain α-ketoacid dehydrogenase kinase (BCKDK) is an in vivo UBE3B substrate. Since BCKDK targets several metabolic pathways, we profiled plasma and cortical metabolomes from Ube3b − /− mice. Nucleotide metabolism and the tricarboxylic acid cycle were among the pathways perturbed. Substrate-induced mitochondrial respiration was reduced in skeletal muscle but not in liver of Ube3b − / − mice. To assess the relevance of these findings to humans, we identified three KOS patients who had compound heterozygous UBE3B mutations. We discovered changes in metabolites from similar pathways in plasma from these patients. Collectively, our results implicate a disease mechanism in KOS, suggest that it is a metabolic encephalomyopathy, and provide an entry to targeted therapies.

AB - Kaufman oculocerebrofacial syndrome (KOS) is a recessive neurodevelopmental disorder characterized by intellectual disability and lack of speech. KOS is caused by inactivating mutations in UBE3B, but the underlying biological mechanisms are completely unknown. We found that loss of Ube3b in mice resulted in growth retardation, decreased grip strength, and loss of vocalization. The brains of Ube3b − / − mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex. Ube3b − / − cortical neurons had abnormal dendritic morphology and synapses. We identified 22 UBE3B interactors and found that branched-chain α-ketoacid dehydrogenase kinase (BCKDK) is an in vivo UBE3B substrate. Since BCKDK targets several metabolic pathways, we profiled plasma and cortical metabolomes from Ube3b − /− mice. Nucleotide metabolism and the tricarboxylic acid cycle were among the pathways perturbed. Substrate-induced mitochondrial respiration was reduced in skeletal muscle but not in liver of Ube3b − / − mice. To assess the relevance of these findings to humans, we identified three KOS patients who had compound heterozygous UBE3B mutations. We discovered changes in metabolites from similar pathways in plasma from these patients. Collectively, our results implicate a disease mechanism in KOS, suggest that it is a metabolic encephalomyopathy, and provide an entry to targeted therapies.

KW - Autism spectrum disorder

KW - BCKDK

KW - Intellectual disability

KW - UBE3B

KW - Ubiquitination

UR - http://www.scopus.com/inward/record.url?scp=85062028654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062028654&partnerID=8YFLogxK

U2 - 10.1073/pnas.1818751116

DO - 10.1073/pnas.1818751116

M3 - Article

C2 - 30808755

AN - SCOPUS:85062028654

VL - 116

SP - 3662

EP - 3667

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -